| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.072 | 0.1 |